HGP-1607/HGP-1501

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameHGP-1607/HGP-1501
Drug Alias NameHGP-1607+HGP-1501HGP-1501/HGP-1607HGP-1501+HGP-1607HCP-1604
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes HGP-1501HGP-1607
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A